[News Brief] Cordex Biologics Grants FarmaMondo Distribution Rights for Zemcelpro®
Cordex Biologics has entered into an agreement granting FarmaMondo SA distribution rights for its cell therapy product, Zemcelpro® (dorocubicel), in…
Global PR
[News Brief] ALR Technologies Signs LOI to Acquire CGM Medical Technology Assets for US$45 Million
ALR Technologies SG has signed a Letter of Intent (LOI) to acquire 100% of CGM Medical Technology Singapore and selected…
[News Brief] StarMed Obtains US FDA Clearance for Thyroid Nodule Ablation System
South Korea-based StarMed Co., Ltd. has received US Food and Drug Administration (FDA) 510(k) clearance for its radiofrequency ablation (RFA)…
[News Brief] Insilico Medicine Initiates Phase III Trial for AI-Discovered IPF Drug Candidate
Insilico Medicine has initiated a Phase III clinical trial evaluating Rentosertib (formerly ISM001-055/INS018_055), an orally administered small-molecule TNIK inhibitor for…
[News Brief] BioMed X and Boehringer Ingelheim Expand XSeed Labs Partnership
BioMed X and Boehringer Ingelheim have expanded their XSeed Labs collaboration by launching a new research team to advance next-generation…
[News Brief] West Introduces Synchrony Prefillable Syringe System in Southeast Asia
West Pharmaceutical Services, Inc. has launched its Synchrony™ prefillable syringe (PFS) system for biologics and vaccines across five Southeast Asian…
[News Brief] Lynk Pharmaceuticals Doses First Patient in LNK01004 Vitiligo Trial
Lynk Pharmaceuticals Co., Ltd. has initiated dosing in its Phase II clinical trial evaluating LNK01004, a topical pan-JAK inhibitor, for…
[News Brief] Senhwa Biosciences Secures NT$500 Million Share Purchase Agreement with GEM
Senhwa Biosciences, Inc. has entered into a share purchase agreement with GEM Global Yield LLC SCS and GEM Yield Bahamas…
[News Brief] Godavari Biorefineries Validates European Patent for Anti-Cancer Molecule
Godavari Biorefineries has announced the successful validation of its European patent for a novel anti-cancer molecule in Spain, the United…
[News Brief] DoH Abu Dhabi, AstraZeneca, and PureHealth Establish Rare Diseases Centre
The Department of Health – Abu Dhabi (DoH), AstraZeneca, and PureHealth have signed a Memorandum of Understanding (MoU) to activate…